Chao‐Lun Lai

940 total citations
60 papers, 661 citations indexed

About

Chao‐Lun Lai is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chao‐Lun Lai has authored 60 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chao‐Lun Lai's work include Atrial Fibrillation Management and Outcomes (10 papers), Acute Myocardial Infarction Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Chao‐Lun Lai is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Acute Myocardial Infarction Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Chao‐Lun Lai collaborates with scholars based in Taiwan, United States and Canada. Chao‐Lun Lai's co-authors include Mei‐Shu Lai, K. Arnold Chan, Yuan‐Teh Lee, Wen‐Jone Chen, Ho‐Min Chen, Chia‐Hsuin Chang, Chien‐Hua Huang, Chih‐Cheng Wu, Ting‐Tse Lin and Matthew Huei‐Ming and has published in prestigious journals such as Circulation, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Chao‐Lun Lai

59 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao‐Lun Lai Taiwan 14 260 143 99 83 79 60 661
Steven P. Dunn United States 15 420 1.6× 151 1.1× 77 0.8× 83 1.0× 67 0.8× 36 789
David Hager United States 13 458 1.8× 188 1.3× 43 0.4× 93 1.1× 78 1.0× 30 865
George V. Moukarbel United States 15 524 2.0× 148 1.0× 88 0.9× 93 1.1× 99 1.3× 63 742
Andréa Penaloza Belgium 19 279 1.1× 185 1.3× 157 1.6× 83 1.0× 138 1.7× 67 1.0k
Nirav Patel United States 20 540 2.1× 197 1.4× 60 0.6× 98 1.2× 121 1.5× 59 942
Neil Orford Australia 18 133 0.5× 180 1.3× 72 0.7× 113 1.4× 156 2.0× 58 864
Francesca Porta Switzerland 12 129 0.5× 219 1.5× 124 1.3× 96 1.2× 221 2.8× 23 551
Moshe Vardi Israel 14 143 0.6× 189 1.3× 55 0.6× 102 1.2× 167 2.1× 34 811
Velvie A. Pogue United States 12 461 1.8× 166 1.2× 52 0.5× 66 0.8× 55 0.7× 20 731
Umesh Gidwani United States 15 321 1.2× 165 1.2× 67 0.7× 117 1.4× 80 1.0× 51 666

Countries citing papers authored by Chao‐Lun Lai

Since Specialization
Citations

This map shows the geographic impact of Chao‐Lun Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Lun Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Lun Lai more than expected).

Fields of papers citing papers by Chao‐Lun Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao‐Lun Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Lun Lai. The network helps show where Chao‐Lun Lai may publish in the future.

Co-authorship network of co-authors of Chao‐Lun Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Chao‐Lun Lai. A scholar is included among the top collaborators of Chao‐Lun Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao‐Lun Lai. Chao‐Lun Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Chao‐Lun, et al.. (2022). The Relationship between Obesity-Related Factors and Graves’ Orbitopathy: A Pilot Study. Medicina. 58(12). 1748–1748. 8 indexed citations
2.
3.
Lai, Chao‐Lun, Kuo‐Hsing Chen, Ting‐Chuan Wang, & K. Arnold Chan. (2021). Mortality of major cardiovascular emergencies among patients admitted to hospitals on weekends as compared with weekdays in Taiwan. BMC Health Services Research. 21(1). 528–528. 3 indexed citations
4.
Liao, Min‐Tsun, Chao‐Lun Lai, Ting‐Chuan Wang, et al.. (2021). Red Cell Distribution Width and Mortality in Patients Undergoing Percutaneous Coronary Intervention. Biomedicines. 10(1). 45–45. 6 indexed citations
5.
Chen, Shiou-Sheng, et al.. (2020). Modified paramedian versus conventional paramedian technique in the residency training: an observational study. BMC Medical Education. 20(1). 211–211. 6 indexed citations
6.
Boon, J.M., Kuan‐Yu Chen, Mu‐Yang Hsieh, et al.. (2019). Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis. International Journal of Cardiology. 291. 152–157. 21 indexed citations
7.
Lin, Ting‐Tse, et al.. (2019). Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation.. Europe PMC (PubMed Central). 35(1). 42–54. 7 indexed citations
8.
Lee, Chih‐Kuo, Chao‐Lun Lai, Ming‐Hsien Lee, et al.. (2019). Reinforcement of patient education improved physicians’ adherence to guideline-recommended medical therapy after acute coronary syndrome. PLoS ONE. 14(6). e0217444–e0217444. 10 indexed citations
9.
Lai, Chao‐Lun, et al.. (2017). Discretionary decisions and disparities in receiving drug-eluting stents under a universal healthcare system: A population-based study. PLoS ONE. 12(6). e0179127–e0179127. 5 indexed citations
10.
Lai, Chao‐Lun, Ho‐Min Chen, Min‐Tsun Liao, & Ting‐Tse Lin. (2017). Abstract 15366: Comparative Effectiveness and Safety Between Reduced Dose Dabigatran, Reduced Dose Rivaroxaban and Warfarin Among Oldest Old Atrial Fibrillation Patients. Circulation. 1 indexed citations
11.
Lai, Chao‐Lun, et al.. (2015). Risk of hip/femur fractures during the initiation period of α‐adrenoceptor blocker therapy among elderly males: a self‐controlled case series study. British Journal of Clinical Pharmacology. 80(5). 1208–1218. 9 indexed citations
12.
Wu, Chih‐Cheng, Mu‐Yang Hsieh, Szu-Chun Hung, et al.. (2015). Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts. Journal of the American Society of Nephrology. 27(4). 1254–1264. 51 indexed citations
13.
Lai, Chao‐Lun, Kuo‐Hsing Chen, Ho‐Min Chen, et al.. (2015). Risk of ischemic stroke during the initiation period of α-blocker therapy among older men. Canadian Medical Association Journal. 188(4). 255–260. 9 indexed citations
14.
Hsieh, Mu‐Yang, et al.. (2014). Impact on Pulmonary Arterial Pressures after Repeated Endovascular Thrombectomy of Dialysis Grafts: A Prospective Follow-up Study. Journal of Vascular and Interventional Radiology. 25(12). 1883–1889. 3 indexed citations
15.
Lai, Chao‐Lun, et al.. (2014). Effects of Atorvastatin and Rosuvastatin on Renal Function in Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology. 115(5). 619–624. 8 indexed citations
16.
Fan, Chieh‐Min, Chao‐Lun Lai, Ai‐Hsien Li, Kuang‐Chau Tsai, & Kuo‐Piao Chung. (2010). Reducing the Door-to-Balloon Time for ST-Segment Elevation Myocardial Infarction: The Result of a Hospital Quality Improvement Initiative. 12(4). 107–113. 2 indexed citations
17.
Li, Ai‐Hsien, et al.. (2010). Two-Year Follow-Up of Tirofiban-Based Management of Non-ST-Elevation Acute Coronary Syndrome-A Single Center Study. Zhōnghuá mínguó xīnzàngxué huì zázhì. 26(1). 19–27. 2 indexed citations
18.
19.
20.
Huang, Chien‐Hua, Wen‐Jone Chen, Matthew Huei‐Ming, et al.. (2001). Ambulance utilization in metropolitan and rural areas in Taiwan.. PubMed. 100(9). 581–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven P. Dunn Breakdown of academic impact, for papers by David Hager Breakdown of academic impact, for papers by George V. Moukarbel Breakdown of academic impact, for papers by Andréa Penaloza Breakdown of academic impact, for papers by Nirav Patel Breakdown of academic impact, for papers by Neil Orford Breakdown of academic impact, for papers by Francesca Porta Breakdown of academic impact, for papers by Moshe Vardi Breakdown of academic impact, for papers by Velvie A. Pogue Breakdown of academic impact, for papers by Umesh Gidwani
Rankless by CCL
2026